Home > Institute Collections > BN DZNE > BN DZNE-LIS > Regulation of Innate Immune Responses by Platelets > print

001     284087
005     20260126110609.0
024 7 _ |a 10.3389/fimmu.2019.01320
|2 doi
037 _ _ |a DZNE-2026-00095
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Secchim Ribeiro, Lucas
|0 P:(DE-2719)9001782
|b 0
|u dzne
245 _ _ |a Regulation of Innate Immune Responses by Platelets
260 _ _ |a Lausanne
|c 2019
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1769421833_1868
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The role of platelets has been extensively studied in the context of coagulation and vascular integrity. Their hemostatic imbalance can lead to known conditions as atherosclerotic plaques, thrombosis, and ischemia. Nevertheless, the knowledge regarding the regulation of different cell types by platelets has been growing exponentially in the past years. Among these biological systems, the innate immune response is remarkably affected by the crosstalk with platelets. This interaction can come from the formation of platelet-leukocyte aggregates, signaling by direct contact between membrane surface molecules or by the stimulation of immune cells by soluble factors and active microparticles secreted by platelets. These ubiquitous blood components are able to sense and react to danger signals, guiding leukocytes to an injury site and providing a scaffold for the formation of extracellular traps for efficient microbial killing and clearance. Using several different mechanisms, platelets have an important task as they regulate the release of different cytokines and chemokines upon sterile or infectious damage, the expression of cell markers and regulation of cell death and survival. Therefore, platelets are more than clotting agents, but critical players within the fine inflammatory equilibrium for the host. In this review, we present pointers to a better understanding about how platelets control and modulate innate immune cells, as well as a summary of the outcome of this interaction, providing an important step for therapeutic opportunities and guidance for future research on infectious and autoimmune diseases.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
650 _ 7 |a cell survival
|2 Other
650 _ 7 |a cytokine production
|2 Other
650 _ 7 |a inflammation
|2 Other
650 _ 7 |a innate immunity
|2 Other
650 _ 7 |a leukocyte migration
|2 Other
650 _ 7 |a platelets
|2 Other
650 _ 7 |a Cytokines
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Apoptosis: immunology
|2 MeSH
650 _ 2 |a Blood Platelets: immunology
|2 MeSH
650 _ 2 |a Cell Communication: immunology
|2 MeSH
650 _ 2 |a Cell Movement: immunology
|2 MeSH
650 _ 2 |a Cell Survival: immunology
|2 MeSH
650 _ 2 |a Cytokines: biosynthesis
|2 MeSH
650 _ 2 |a Extracellular Traps: immunology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Immunity, Innate
|2 MeSH
650 _ 2 |a Infections: immunology
|2 MeSH
650 _ 2 |a Inflammation: immunology
|2 MeSH
650 _ 2 |a Leukocytes: immunology
|2 MeSH
650 _ 2 |a Phagocytosis: immunology
|2 MeSH
650 _ 2 |a Signal Transduction: immunology
|2 MeSH
700 1 _ |a Migliari Branco, Laura
|b 1
700 1 _ |a Franklin, Bernardo S.
|b 2
773 _ _ |a 10.3389/fimmu.2019.01320
|g Vol. 10, p. 1320
|0 PERI:(DE-600)2606827-8
|p 1320
|t Frontiers in immunology
|v 10
|y 2019
|x 1664-3224
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/284087/files/fimmu-10-01320.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/284087/files/fimmu-10-01320.pdf?subformat=pdfa
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-2719)9001782
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-28
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT IMMUNOL : 2022
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-12-29T15:23:07Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-12-29T15:23:07Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-28
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-28
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-12-29T15:23:07Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-28
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b FRONT IMMUNOL : 2022
|d 2024-12-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-28
915 _ _ |a Hosted Content
|0 StatID:(DE-HGF)10000
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-28
920 _ _ |l yes
980 _ _ |a journal
980 _ _ |a I:(DE-2719)1040260
980 1 _ |a UNRESTRICTED
980 1 _ |a EXTERN4VITA
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21